Impact of COVID-19 on Respiratory Diseases Market
What are Monoclonal Antibodies and How Can They Treat COVID-19?
medtech-news-for-siemens-paragon-28-pulnovo-endotronix-abbott
Siemens Healthineers’s COVID-19 Antig...

Siemens Healthineers received Emergency Use Authorization for CLINITEST® Rapid COVID-19 Antigen Self-Test b...

pharma-news-for-accutar-bio-thera-nykode-heat-biologics-elusys
Accutar’s Phase I clinical tria...

FDA approves IND application of Accutar for a prostate cancer treatment trial The US Food and Drug Administ...

monoclonal-antibody-therapy
What are Monoclonal Antibodies and Ho...

An antibody is a protein produced by the immune system in response to an infection in the body. Whereas, a&...

An Exploratory Analysis of the Rare and Inherited Pompe Disease
Pompe Disease: Causes, Symptoms, Diagnosis, Pathology, Current Marketed and Emerging Drugs in the...

Pompe disease is an inherited disorder caused by the buildup of a complex sugar called glycogen in the body's cells. The accumulation of glycogen in certain organs and tissues, especially muscles,...


Pertussis-vaccines
Pertussis Vaccines: Whole-cell & Acellular Vaccines, Different Types & Manufacturers al...

Pertussis, also commonly known as whooping cough, is a very highly contagious respiratory disease. It is caused by the bacterium Bordetella Pertussis. Pertussis can be a serious disease for people...


pertussis-treatment-outlook
What is Driving the Pertussis Treatment Market Forward?

Pertussis, which was first discovered in the Paris epidemic of 1578, is distinguished by a 2-week paroxysmal cough, an inspiratory whoop, posttussive emesis, and posttussive syncope. Pertussis is ...


medtech-news-for-baxter-medtronic-atacor-brainq
BrainQ’s EMAGINE Trial; AtaCor’s EV-ICD study; Urotronic’s Optilume Urethral Dr...

First patient enrolled in BrainQ's Pivotal Trial, EMAGINE™, for frequency-tuned electromagnetic field therapy to reduce disability following Ischemic Stroke   On December 09, 2021, Brain...


medtech-news-for-boston-scientific-bd-roche-linus-helioliver
Boston Scientific’s MODULAR CRM System; Restore Medical’s ContraBand clinical trial r...

Boston Scientific initiates trial to evaluate industry's first Modular CRM System  On December 02, 2021, Boston Scientific Corporation started the MODULAR ATP clinical trial to examine the...


pharma-news-for-bluebird-bio-fda-twist-bioscience-sosei-heptares
Bluebird bio may get gene therapy approved in the US; Neurocrine pens $2.6B pact with Sosei Hepta...

Bluebird bio may finally get a gene therapy approved in the US Bluebird bio may get gene therapy approved in the US. The Cambridge, MA biotech declared that the FDA had accepted and given prior...


Editor's Pick
22 Healthcare Trends & Innovations to Watch in 2022 and Beyond

With the advent of new-age healthcare industry trends that are evident as of now, there...

Assessment of Key Products that Got FDA Approval in Second Half (H2) of 2021

Although COVID-19 continued to dominate headlines in 2021, pharmaceutical companies did...

Analyzing the Key Trends Driving the Biosimilar Market Growth

The Biosimilars market is growing at a breakneck pace. The biosimilar market provides a...

CAR-T Cell Therapy aka Miraculous Technology: Mapping the Market, Approved Th...

Chimeric antigen receptor T-cell (CAR T) therapies are shown to have transformative pot...

Myelodysplastic Syndromes (MDS): Key Pharma Players Unveiling Updated Finding...

There has been limited progress in the approval of novel agents in MDS. It has been a l...